This also corresponds with earlier studies in Tanzania by Mosha et al., and Mporogo et al., where high SP dose (≥3) was associated with 60–80% reduced odds of third trimester malaria parasitaemia [16, 29]. This evidence concerns the gene TFF2 and malaria.